Disc Medicine Gets FDA Fast-Track Voucher for Rare Skin Disease Treatment

Disc Medicine receives FDA's Commissioner's National Priority Voucher for bitopertin, accelerating approval timeline to 1-2 months for EPP patients who suffer severe sun sensitivity.